Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Options and Sells Shares
SEC Form 4
Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock on March 4th and 5th, 2025, under a pre-arranged trading plan.
Summary
- On March 4th and 5th, 2025, Marc N. Casper, Chairman and CEO of Thermo Fisher Scientific, engaged in transactions involving the company's common stock.
- Casper exercised stock options to acquire 10,000 shares on March 4th and 8,000 shares on March 5th, both at a price of $253.99 per share.
- Simultaneously, Casper sold shares of common stock on both days at varying prices ranging from $513.43 to $524.73 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on August 7, 2024.
- Following these transactions, Casper directly owns 115,173.623 shares of common stock.
- Casper also has indirect ownership through various trusts and entities.
- He also owns options to purchase 53,250 shares.
Sentiment
Score: 5
Explanation: The document reflects routine insider transactions under a pre-arranged plan, which is neither particularly positive nor negative. The CEO is realizing gains from stock options, which is a common practice.
Industry Context
Insider transactions are common, and the use of a 10b5-1 plan suggests these sales were pre-planned and not based on any specific non-public information. Investors often monitor insider activity for signals about a company's prospects, but routine sales under a pre-arranged plan are generally less significant.
Comparison to Industry Standards
- Comparing Casper's transactions to other CEOs in the life sciences and diagnostics industries, similar patterns of option exercises and share sales are common.
- For example, CEOs at companies like Danaher or Agilent Technologies often utilize 10b5-1 plans for regular stock sales.
- The size of Casper's transactions is within a typical range for CEOs of companies with similar market capitalizations.
Key Dates
| Date | Description |
|---|---|
| 02/26/2020 | First vesting date of stock options. |
| 02/26/2021 | Second vesting date of stock options. |
| 02/26/2022 | Third vesting date of stock options. |
| 02/26/2023 | Fourth vesting date of stock options. |
| 08/07/2024 | Date of adoption of Rule 10b5-1 trading plan. |
| 03/04/2025 | Date of first transaction: exercising options and selling shares. |
| 03/05/2025 | Date of second transaction: exercising options and selling shares. |
| 03/06/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.